Oryzon Genomics SA (ORY) — Cash Flow Quality Index
Oryzon Genomics SA (ORY) has a Cash Flow Quality Index of -2.29x as of June 2023. Operating cash flow of €-2.41 Million is below net income of €1.05 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore ORY operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Oryzon Genomics SA Cash Flow Quality Index (2014–2014)
Historical Cash Flow Quality Index for Oryzon Genomics SA across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see how efficiently does Oryzon Genomics SA generate cash.
Annual Cash Flow Quality Index for Oryzon Genomics SA (2014–2014)
Year-by-year earnings quality comparison for Oryzon Genomics SA.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2014 | 1.82x | €12.13 Million | €6.65 Million | — |